US2018256648A9PendingUtilityA9
Adherent cells from adipose or placenta tissues and use thereof in therapy
Est. expirySep 19, 2027(~1.2 yrs left)· nominal 20-yr term from priority
A61P 9/10A61P 35/00A61P 7/02A61P 37/06A61P 43/00A61P 9/00A61P 19/00A61P 19/04A61P 13/12A61P 19/08A61P 19/02A61P 17/02A61P 19/10A61K 35/28A61K 35/35A61K 35/50A61K 35/36
57
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
A method of treating ischemia in a subject in need thereof is disclosed. The method comprising administering to the subject a therapeutically effective amount of adherent cells of a tissue selected from the group consisting of a placenta and an adipose tissue, thereby treating the ischemia in the subject. A method of treating a medical condition requiring connective tissue regeneration and/or repair is also disclosed.
Claims
exact text as granted — not AI-modified1 . A method of treating ischemia in a subject in need thereof, the method comprising administering to the subject a therapeutically effective amount of adherent cells of a tissue selected from the group consisting of a placenta and an adipose tissue, thereby treating the ischemia in the subject.
2 - 30 . (canceled)Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.